Adverse event totals12

The totals the trial posted for each group.

1 to 12 of 12

Total	Group	Affected	At risk
Total, all-cause mortality	PG324 Ophthalmic Solution 0.01%	0	74
Total, all-cause mortality	PG324 Ophthalmic Solution 0.02%	0	73
Total, all-cause mortality	Netarsudil (AR-13324) Ophthalmic Solution	0	78
Total, all-cause mortality	Latanoprost Ophthalmic Solution	0	73
Total, other adverse events	PG324 Ophthalmic Solution 0.01%	46	73
Total, other adverse events	PG324 Ophthalmic Solution 0.02%	55	73
Total, other adverse events	Netarsudil (AR-13324) Ophthalmic Solution	49	78
Total, other adverse events	Latanoprost Ophthalmic Solution	12	73
Total, serious adverse events	PG324 Ophthalmic Solution 0.01%	0	74
Total, serious adverse events	PG324 Ophthalmic Solution 0.02%	0	73
Total, serious adverse events	Netarsudil (AR-13324) Ophthalmic Solution	0	78
Total, serious adverse events	Latanoprost Ophthalmic Solution	3	73

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02057575/event-totals